摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(2-deoxy-β-D-erythropentofuranosyl)-4-isobutyrylamino-7H-pyrazolo[3,4-d][1,2,3]triazine | 736138-72-0

中文名称
——
中文别名
——
英文名称
7-(2-deoxy-β-D-erythropentofuranosyl)-4-isobutyrylamino-7H-pyrazolo[3,4-d][1,2,3]triazine
英文别名
N-[7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazolo[3,4-d]triazin-4-yl]-2-methylpropanamide
7-(2-deoxy-β-D-erythropentofuranosyl)-4-isobutyrylamino-7H-pyrazolo[3,4-d][1,2,3]triazine化学式
CAS
736138-72-0
化学式
C13H18N6O4
mdl
——
分子量
322.324
InChiKey
OERQPYHUBJWINP-IVZWLZJFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    135
  • 氢给体数:
    3
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-(2-deoxy-β-D-erythropentofuranosyl)-4-isobutyrylamino-7H-pyrazolo[3,4-d][1,2,3]triazine吡啶N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 4.33h, 生成 7-[2-deoxy-5-O-(4,4'-dimethoxytriphenyl)methyl-β-D-erythropentofuranosyl]-4-isobutyrylamino-7H-pyrazolo[3,4-d][1,2,3]triazine-3'-[(2-cyanoethyl)-N,N-diisopropylphosphoramidite]
    参考文献:
    名称:
    Pyrazolo[3,4-d][1,2,3]triazine DNA:  Synthesis and Base Pairing of 7-Deaza-2,8-diaza-2‘-deoxyadenosine
    摘要:
    7-Deaza-2,8-diaza-2'-deoxyadenosine (4) was synthesized from 8-aza-7-deaza-2'-deoxyadenosine (1) via the 1,N-6-etheno derivative 5. Ring opening with sodium hydroxide followed by ring closure in the presence of sodium nitrite formed the tricyclic intermediate 5 from which the transiently introduced "etheno" moiety was removed with NBS. Compound 4 was converted to the phosphoramidite 11, which was employed in solid-phase oligonucleotide synthesis. Base pairing studies on 4, incorporated in a 12-mer duplex, showed that this adenine nucleoside analogue forms a strong base pair with dG but not with dT. This novel base pair is as stable as that of the canonical dA-dT pair. As a result of the absence of nitrogen-7 compound 4 is expected to form a face to face base pair with dG.
    DOI:
    10.1021/jo040150i
  • 作为产物:
    参考文献:
    名称:
    Pyrazolo[3,4-d][1,2,3]triazine DNA:  Synthesis and Base Pairing of 7-Deaza-2,8-diaza-2‘-deoxyadenosine
    摘要:
    7-Deaza-2,8-diaza-2'-deoxyadenosine (4) was synthesized from 8-aza-7-deaza-2'-deoxyadenosine (1) via the 1,N-6-etheno derivative 5. Ring opening with sodium hydroxide followed by ring closure in the presence of sodium nitrite formed the tricyclic intermediate 5 from which the transiently introduced "etheno" moiety was removed with NBS. Compound 4 was converted to the phosphoramidite 11, which was employed in solid-phase oligonucleotide synthesis. Base pairing studies on 4, incorporated in a 12-mer duplex, showed that this adenine nucleoside analogue forms a strong base pair with dG but not with dT. This novel base pair is as stable as that of the canonical dA-dT pair. As a result of the absence of nitrogen-7 compound 4 is expected to form a face to face base pair with dG.
    DOI:
    10.1021/jo040150i
点击查看最新优质反应信息

文献信息

  • Pyrazolo[3,4-<i>d</i>][1,2,3]triazine DNA:  Synthesis and Base Pairing of 7-Deaza-2,8-diaza-2‘-deoxyadenosine
    作者:Frank Seela、Meike Lindner、Virginie Glaçon、Wenqing Lin
    DOI:10.1021/jo040150i
    日期:2004.7.1
    7-Deaza-2,8-diaza-2'-deoxyadenosine (4) was synthesized from 8-aza-7-deaza-2'-deoxyadenosine (1) via the 1,N-6-etheno derivative 5. Ring opening with sodium hydroxide followed by ring closure in the presence of sodium nitrite formed the tricyclic intermediate 5 from which the transiently introduced "etheno" moiety was removed with NBS. Compound 4 was converted to the phosphoramidite 11, which was employed in solid-phase oligonucleotide synthesis. Base pairing studies on 4, incorporated in a 12-mer duplex, showed that this adenine nucleoside analogue forms a strong base pair with dG but not with dT. This novel base pair is as stable as that of the canonical dA-dT pair. As a result of the absence of nitrogen-7 compound 4 is expected to form a face to face base pair with dG.
查看更多

同类化合物

酪氨酸,2-甲氧基-O-甲基- 达美司特 百里酚-6-磺化三(2-羟基乙基)铵 吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 吡唑并[1,5-a][1,3,5]三嗪-2,4-二胺 吡唑并[1,5-D][1,2,4]三嗪酮 吡唑并[1,5-A]-1,3,5-三嗪-2,4(1H,3H)-二酮 N4-(1,1-二甲基乙基)-7-甲基吡唑并(1,5-a)-1,3,5-三嗪-2,4-二胺盐酸盐 N'-甲酰基-4-氨基吡唑并[5,1-c][1,2,4]三嗪-3-甲酰肼 8-苄基-2-甲基-4-(N-甲基氨基)吡唑并[1,5-a]-1,3,5-三嗪 8-溴-4-氯-2-(甲基硫代)吡唑并[1,5-a][1,3,5]三嗪 7-甲基-6H-吡唑并[4,5-e][1,2,3]三嗪-4-酮 7-甲基-1,7-二氢-4H-吡唑并[3,4-d][1,2,3]三嗪-4-酮2-氧化物 7-(叔丁基)吡唑并[1,5-a][1,3,5]三嗪-4(3H)-酮 5,6-二氢吡唑并[1,5-d][1,2,4]三嗪-4,7-二酮 4-甲氧基吡唑并[1,5-a][1,3,5]三嗪 4-氯-2-(甲硫基)吡唑并[1,5-a][1,3,5]三嗪 4-氨基-7-甲基吡唑并[5,1-C][1,2,4]三嗪-3-甲腈 4,7-二甲基吡唑并[5,1-c][1,2,4]三嗪-3-羧酸乙酯 4,7-二甲基吡唑并[5,1-C][1,2,4]三嗪-3-羧酸 4,6-二氢-6-(碘乙酰基)-3-甲基-4-亚甲基吡唑并[5,1-c][1,2,4]三嗪 3-甲氧基-2H-吡唑并[4,3-e][1,2,4]三嗪 3-(1,1-二甲基乙基)-7-(5-甲基-3-异恶唑基)-2-[(1-甲基-1H-1,2,4-三唑-5-基)甲氧基]吡唑并[1,5-d][1,2,4]三嗪 3,4-二甲基吡唑并[5,1-c][1,2,4]三嗪 2-甲基吡唑并[1,5-d][1,2,4]三嗪-4(5H)-酮 2-甲基-4-(N-甲基氨基)-8-[(2-噻吩基)甲基]吡唑并[1,5-a]-1,3,5-三嗪 2-Thi氧代-2,3-二氢吡唑并[1,5-a][1,3,5]噻嗪-4(1H)-酮 2-(甲基硫代)吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 2,4-二氨基-吡唑并(1,5-a)-S-三嗪盐酸盐半水合物 2,4-二(甲基氨基)-7-甲基吡唑并(1,5-a)-S-三嗪 1-(4,7-二甲基吡唑并[5,1-c][1,2,4]三氮杂-3-基)-1-乙酮 4-(2,4-dichlorophenyl)-8-(3-pentyl)-7-ethyl-2-methyl-pyrazolo[1,5-a]-1,3,5-triazine 2-(4-tert-butylphenyl)-4-({3-[(2,3-dihydro-1H-inden-2-yl)amino]-2,2-difluoropropyl}amino)-6H,7H-pyrazolo[1,5-a][1,3,5]triazin-7-one 2-(4-tert-butylphenyl)-4-{[3-(dimethylamino)propyl]amino}-8-[(6-methylpyridin-3-yl)methyl]-6H,7H-pyrazolo[1,5-a][1,3,5]triazin-7-one 4-methyl-N-(1-methyl-1-phenylethyl)-2-phenyl-1,2,3,4-tetrahydropyrazolo[5,1-c][1,2,4]triazine-8-carboxamide 2,4-diphenyl-pyrazolo[1,5-a][1,3,5]triazine 3H-8-carbonitrile-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-methylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-carboxylic acid ethyl ester 2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-trifluoromethylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-8-methylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-8-iodopyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-chloro-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-bromo-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 6-[4-(1-hydroxy-1-methylethyl)phenyl]-2-methyl-5H-1,5,7,7a-tetraazainden-4-one Pyrazolo<3,2-f><1,2,4>triazin-4(3H)-on methyl 3,7-dimethyl-4-oxo-4,6-dihydro-pyrazolo[5,1-c][1,2,4]triazine-8-carboxylate 2-(4-tert-butylphenyl)-4-{[3-(4-chloro-3-methylphenoxy)propyl]sulfanyl}-6H,7H-pyrazolo[1,5-a] [1,3,5]triazin-7-one